+499.5%
MRNA vs ROL
-35.4%
+534.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ROL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.4% | -2.7% | -2.3% |
| 7D | +5.5% | -1.4% | +6.9% | +5.7% |
| 30D | +158.7% | -4.1% | +162.8% | +160.5% |
| 3M | +182.1% | -22.5% | +204.6% | +193.6% |
| 6M | +151.8% | -37.7% | +189.5% | +178.9% |
| YTD | +393.6% | -39.6% | +433.1% | +438.7% |
| 1Y | +499.5% | -36.0% | +535.5% | +508.6% |
| All | +499.5% | -35.4% | +534.9% | +508.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ROL.
Daily Out/Under-Performance
Portfolio return minus ROL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ROL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ROL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling